Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms

논문상세정보
' Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Claudins
  • Spectrin
  • Ubiquitin.
  • blood-brain barrier
  • occludin
  • schizophrenia
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
461 0

0.0%

' Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms' 의 참고문헌

  • α II-spectrin breakdown products(SBDPs) : diagnosis and outcome in severe traumatic brain injury patients
    Mondello S [2010]
  • Ubiquitin-mediated proteolysis : biological regulation via destruction
  • The reliability and validity of scale for the assessment of the positive symptoms
    Erkoç Ş [1991]
  • The reliability and validity of scale for the assessment of the negative symptoms
    Erkoç Ş [1991]
  • The neuropathology of schizophrenia : a selective review of past studies and emerging themes in brain structure and cytoarchitecture
    Bakhshi K [2015]
  • The blood-brain barrier in psychosis
    Pollak TA [2018]
  • Spectrin breakdown products(SBDPs)as potential biomarkers for neurodegenerative diseases
    Yan XX [2012]
  • Schizophrenia
    Kahn RS [2015]
  • Reliability and validity of the Global Assessment of Functioning Scale in clinical outpatients with depressive disorders
  • Proteolysis of submembrane cytoskeletal proteins ankyrin-G and αII-spectrin following diffuse brain injury : a role in white matter vulnerability at Nodes of Ranvier
    Reeves TM [2010]
  • Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood
    Bousman CA [2010]
  • Polymorphism of the CLDN5 gene and schizophrenia in an Iranian population
    Omidinia E [2014]
  • Neurovascular unit dysfunction and blood-brain barrier hyperpermeability contribute to schizophrenia neurobiology : a theoretical integration of clinical and experimental evidence
    Najjar S [2017]
  • Methods for assessing positive and negative symptoms
  • Matrix metalloproteinase-9 as a novel player in synaptic plasticity and schizophrenia
    Lepeta K [2015]
  • Low wnt/b-catenin signaling determines leaky vessels in the subfornical organ and affects water homeostasis in mice
    Benz F [2019]
  • Increased serum levels of spectrin degradation products in patients with schizophrenia
    Cetin I [2018]
  • Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation
    Cai HQ [2020]
  • In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions : link to spatial receptor occupancy
    Loryan I [2016]
  • Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients : relationship to negative symptomatology
    Müller N [1995]
  • Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
  • Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia
  • Functional morphology of the blood-brain barrier in health and disease
    Liebner S [2018]
  • ECDEU assessment manual for psychopharmacology
    Guy W [1976]
  • Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia
    Greene C [2018]
  • Detection of alpha II-spectrin breakdown products in the serum of neonates with congenital heart disease
    Jain P [2014]
  • Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts
    Altar CA [2005]
  • Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders : identification of subgroups with immune responses and blood-CSF barrier dysfunction
    Bechter K [2010]
  • Breaching the blood-brain barrier as a gate to psychiatric disorder
    Shalev H [2009]
  • Blood-brain barrier regulation in psychiatric disorders
    Kealy J [2020]
  • Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders
    Greene C [2020]
  • Blood occludin level as a potential biomarker for early blood brain barrier damage following ischemic stroke
    Pan R [2017]
  • Asymmetrical changes in the fodrin alpha subunit in the superior temporal cortices in schizophrenia
    Kitamura N [1998]
  • Association study of a polymorphism of nonerythroid alpha-spectrin gene with schizophrenia
    Murakami N [1999]
  • Application of cDNA microarrays to examine gene expression differences in schizophrenia
    Vawter MP [2001]
  • Antibodies to NMDA receptor, blood-brain barrier disruption and schizophrenia : a theory with unproven links
    Titulaer MJ [2014]
  • Adverse effects of antipsychotics on micro-vascular endothelial cells of the human blood-brain barrier
    Elmorsy E [2014]